API Synthesis and Manufacturing, Large Molecule

Jul 19, 2018
By BioPharm International Editors
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
Jul 18, 2018
By BioPharm International Editors
CELLforCURE will produce cancer CAR-T treatments for Novartis at a manufacturing facility in Les Ulis (Essonne), France.
Jul 09, 2018
By BioPharm International Editors
Report predicts PAT, NIRS, continuous bioprocessing, and a ‘technological arms race’ could improve biopharma manufacturing efficiencies.
Jul 01, 2018
BioPharm International
Late-stage and commercial biomanufacturing pose a challenge to cell-culture processing.
Jun 25, 2018
By BioPharm International Editors
Minakem’s facility in Belgium enhances capacity to scale production of highly potent ingredients for small to full GMP batches.
Jun 15, 2018
BioPharm International
Biosimilars and biobetters have their own unique manufacturing strategies and challenges.
Jun 07, 2018
By BioPharm International Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
Jun 01, 2018
By BioPharm International Editors
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
May 16, 2018
By BioPharm International Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
Apr 20, 2018
By BioPharm International Editors
The new platform is expected to speed up cell line development.
native1_300x100
lorem ipsum